Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference7 articles.
1. Takeshita A, Asou N, Atsuta Y, Sakura T, Ueda Y, Sawa M, Dobashi N, Taniguchi Y, Suzuki R, Nakagawa M, Tamaki S, Hagihara M, Fujimaki K, Furumaki H, Obata Y, Fujita H, Yanada M, Maeda Y, Usui N, Kobayashi Y, Kiyoi H, Ohtake S, Matsumura I, Naoe T, Miyazaki Y (2019) Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study. Leukemia 33(2):358–370. https://doi.org/10.1038/s41375-018-0233-7
2. Suzukawa M, Sugiyama A, Nakazora T, Kawasaki Y, Tominaga T, Shinohara K (2010) Acute promyelocytic leukemia presenting initially with pancytopenia and severe hypocellular marrow which was successfully treated with all-trans retinoic acid and chemotherapy. Bull Yamaguchi Med Sch 57(1–2):9–15
3. Yamamoto K, Kodaka T, Maruoka H, Sakane E, Tsunemine H, Itoh K, Akasaka H, Takahashi T (2015) Persistent hypoplastic acute promyelocytic leukemia with a novel chromosomal abnormality of 46, XY, t(15;17), t(9;11)(q13;p13). J Clin Exp Hematop 55(2):71–76. https://doi.org/10.3960/jslrt.55.71
4. Nakamura T, Makiyama J, Matsuura A, Kurohama H, Kitanosono H, Ito M, Yoshida S, Miyazaki Y (2018) Hypoplastic acute promyelocytic leukemia with continuous hypocellular bone marrow after remission. Rinsho Ketsueki 59(4):414–419. https://doi.org/10.11406/rinketsu.59.414
5. Tsujikawa T, Tasaki T, Hosono N, Mori T, Makino A, Kiyono Y, Zanotti-Fregonara P, Yamauchi T, Okazawa H (2019) (18)F-FLT PET/MRI for bone marrow failure syndrome-initial experience. EJNMMI Res 9(1):16. https://doi.org/10.1186/s13550-019-0490-0